July 09, 2018
2 min watch
Save

VIDEO: Foundation progresses in fighting inherited retinal diseases

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.

NEWPORT BEACH, Calif. — Jason Menzo, chief operating officer of the Foundation Fighting Blindness, the leading private funder of research for inherited retinal diseases, discusses progress the organization has helped fund, such as the approval of Luxturna (voretigene neparvovec-rzyl, Spark Therapeutics). To find out more about clinical trials ongoing in the inherited retinal disease space, go to www.blindness.org.